share_log

Eiger BioPharmaceuticals | 424B5: Prospectus

SEC announcement ·  Mar 25, 2022 16:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more